Bain Capital Life Sciences Opportunities IV, L.P.

13D and 13G Filings

13D/G filings
13G on 2 securities
CIK
0002015553
All SEC filings
View on sec.gov
Issuer % of Class Filed
Schedule 13G · 2 securities · passive
ADC Therapeutics SA 13G
ADCT · H0036K147
10.0% 10/29/2026
Event 10/22/2026
Olema Pharmaceuticals, Inc. 13G/A
OLMA · 68062P106
8.2% 5/15/2026
Event 3/31/2026

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.